The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells

Cell Immunol. 2006 Aug;242(2):110-7. doi: 10.1016/j.cellimm.2006.10.002. Epub 2006 Nov 20.

Abstract

We have previously determined the protective efficacy of intranasal vaccination with chlamydial protease-like activity factor (CPAF) against genital chlamydial infection. Since T-helper 1 (Th1) responses are important for anti-chlamydial immunity, we examined the contribution of CD4(+) T cells in CPAF mediated immunity against intravaginal (i.vag.) Chlamydia muridarum infection in C57BL/6 mice. CPAF+IL-12 vaccination induced antigen-specific CD4(+) T cells that secreted elevated levels of IFN-gamma, and generated strong humoral responses. The protective effects of CPAF vaccination against genital chlamydial challenge were abrogated by anti-CD4 neutralizing antibody treatment. Moreover, anti-chlamydial immunity could be adoptively transferred to naïve recipients using CPAF-specific CD4(+) T cells. Therefore, CPAF mediated anti-chlamydial immunity is highly dependent upon antigen-specific CD4(+) T cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intranasal
  • Adoptive Transfer
  • Animals
  • Bacterial Vaccines / administration & dosage
  • Bacterial Vaccines / immunology*
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Proliferation
  • Chlamydia / enzymology*
  • Chlamydia / immunology*
  • Endopeptidases / immunology*
  • Female
  • Interleukin-12 / administration & dosage
  • Interleukin-12 / immunology
  • Mice
  • Mice, Inbred C57BL
  • Oviducts / immunology
  • Th1 Cells / immunology

Substances

  • Bacterial Vaccines
  • Interleukin-12
  • Endopeptidases
  • CPA factor